Potential risk of disease modifying therapies on neoplasm development and coadjutant factors in multiple sclerosis outpatients

Abstract Neoplasm development in Multiple Sclerosis (MS) patients treated with disease-modifying therapies (DMTs) has been widely discussed. The aim of this work is to determine neoplasm frequency, relationship with the prescription pattern of DMTs, and influence of the patients’ baseline characteri...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Rosalía Gil-Bernal, Juan Luis González-Caballero, Raúl Espinosa-Rosso, Carmen Gómez-Gómez
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/9e0434f4136d47b6b5db10f717e47481
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares